Irodalom:
1. Akagi I, Miyashita M, Makino H, Nomura T, Hagiwara N, Takahashi K, Cho K, Mishima T, Takizawa T,
Tajiri T.: SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell
carcinoma. Ann Surg Oncol. 2008;15(10):2965-75.
Gastro 2009.qxd 5/9/2009 1:41 PM Page 86
A nyelõcsõ 87
2. Baba Y, Iyama K, Ikeda K, Ishikawa S, Hayashi N, Miyanari N, Sado Y, Ninomiya Y, Baba H.: The
expression of type IV collagen alpha6 chain is related to the prognosis in patients with esophageal squamous
cell carcinoma. Ann Surg Oncol. 2008;15(2):555-65.
3. Baba Y, Iyama KI, Hirashima K, Nagai Y, Yoshida N, Hayashi N, Miyanari N, Baba H.: Laminin-332
promotes the invasion of oesophageal squamous cell carcinoma via PI3K activation. Br J Cancer. 2008;
98(5):974-80.
4. Bognar G, Imdahl A, Ledniczky G, Ondrejka P.: Possible role of human papilloma virus infection in
response to neoadjuvant therapy in patients with esophageal cancer. Hepatogastroenterology. 2008;
55(81):93-7.
5. Brücher BL, Keller G, Werner M, Müller U, Lassmann S, Cabras AD, Fend F, Busch R, Stein H, Allescher
HD, Molls M, Siewert JR, Höfler H, Specht K.: Using Q-RT-PCR to measure cyclin D1, TS, TP, DPD,
and Her-2/neu as predictors for response, survival, and recurrence in patients with esophageal squamous
cell carcinoma following radiochemotherapy. Int J Colorectal Dis. 2009;24(1):69-77.
6. Cai HY, Wang XH, Tian Y, Gao LY, Zhang LJ, Zhang ZY.: Changes of serum p53 antibodies and clinical
significance of radiotherapy for esophageal squamous cell carcinoma. World J Gastroenterol. 2008;
14(25):4082-6.
7. Carneiro A, Isinger A, Karlsson A, Johansson J, Jönsson G, Bendahl PO, Falkenback D, Halvarsson B,
Nilbert M.: Prognostic impact of array-based genomic profiles in esophageal squamous cell cancer.
BMC Cancer. 2008;8:98.
8. Chen MF, Fang FM, Lu CH, Lu MS, Chen WC, Lee KD, Lin PY.: Significance of nuclear accumulation
of Foxo3a in esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2008;71(4):1220-9.
9. Ding XW, Wang XG, Luo HS, Tan SY, Gao S, Luo B, Jiang H.: Expression and prognostic roles of Eag1
in resected esophageal squamous cell carcinomas. Dig Dis Sci. 2008;53(8):2039-44.
10. Font A, Salazar R, Maurel J, Taron M, Ramirez JL, Tabernero J, Gallego R, Casado E, Manzano JL,
Carcereny E, Guix M, Fernández-Llamazares J, Rosell R.: Cisplatin plus weekly CPT-11/docetaxel in
advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3
and UGT1A1 polymorphisms. Cancer Chemother Pharmacol. 2008;62(6):1075-83.
11. Fujiwara S, Noguchi T, Takeno S, Kimura Y, Fumoto S, Kawahara K.: Hypermethylation of p16 gene
promoter correlates with loss of p16 expression that results in poorer prognosis in esophageal squamous
cell carcinomas. Dis Esophagus. 2008;21(2):125-31.
12. Hayashi K, Motoyama S, Sugiyama T, Izumi J, Anbai A, Nanjo H, Watanabe H, Maruyama K, Minamiya Y,
Koyota S, Koizumi Y, Takasawa S, Murata K, Ogawa J.: REG Ialpha is a reliable marker of
chemoradiosensitivity in squamous cell esophageal cancer patients. Ann Surg Oncol. 2008;15(4):1224-31.
13. Hsu PK, Li AF, Wang YC, Hsieh CC, Huang MH, Hsu WH, Hsu HS.: Reduced membranous beta-catenin
protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the
esophagus. J Thorac Cardiovasc Surg. 2008;135(5):1029-35.
14. Inoue A, Moriya H, Katada N, Tanabe S, Kobayashi N, Watanabe M, Okayasu I, Ohbu M.: Intratumoral
lymphangiogenesis of esophageal squamous cell carcinoma and relationship with regulatory factors
and prognosis. Pathol Int. 2008;58(10):611-9.
15. Izzo JG, Wu X, Wu TT, Huang P, Lee JS, Liao Z, Lee JH, Bhutani MS, Hofstetter W, Maru D, Hung MC,
Ajani JA.: Therapy-induced expression of NF-kappaB portends poor prognosis in patients with localized
esophageal cancer undergoing preoperative chemoradiation. Dis Esophagus. 2008 Nov 19. [Epub ahead
of print]
16. Kim MK, Cho KJ, Kwon GY, Park SI, Kim YH, Kim JH, Song HY, Shin JH, Jung HY, Lee GH, Choi KD,
Kim SB.: ERCC1 predicting chemoradiation resistance and poor outcome in oesophageal cancer.
Eur J Cancer. 2008;44(1):54-60.
Gastro 2009.qxd 5/9/2009 1:41 PM Page 87
88 Gastro Update 2009
17. Kim MK, Cho KJ, Kwon GY, Park SI, Kim YH, Kim JH, Song HY, Shin JH, Jung HY, Lee GH, Choi KD,
Kim SB.: Patients with ERCC1-negative locally advanced esophageal cancers may benefit from preoperative
chemoradiotherapy. Clin Cancer Res. 2008 Jul 1;14(13):4225-31.
18. Kim YT, Park JY, Jeon YK, Park SJ, Song JY, Kang CH, Sung SW, Kim JH.: Aberrant promoter CpG
island hypermethylation of the adenomatosis polyposis coli gene can serve as a good prognostic factor
by affecting lymph node metastasis in squamous cell carcinoma of the esophagus. Dis Esophagus. 2008
Oct 1. [Epub ahead of print]
19. Kuo KT, Wang HW, Chou TY, Hsu WH, Hsu HS, Lin CH, Wang LS.: Prognostic Role of PGE2 Receptor
EP2 in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 2008 Dec 3. [Epub ahead of print]
20. Kuramochi H, Tanaka K, Oh D, Lehman BJ, Dunst CM, Yang DY, De Meester SR, Hagen JA, Danenberg
KD, De Meester TR, Danenberg PV.: Thymidylate synthase polymorphisms and mRNA expression are
independent chemotherapy predictive markers in esophageal adenocarcinoma patients. Int J Oncol.
2008 Jan;32(1):201-8.
21. Lee EJ, Lee BB, Han J, Cho EY, Shim YM, Park J, Kim DH.: CpG island hypermethylation of E-cadherin
(CDH1) and integrin alpha4 is associated with recurrence of early stage esophageal squamous cell
carcinoma. Int J Cancer. 2008 Nov 1;123(9):2073-9.
22. Miyamoto K, Kusumi T, Sato F, Kawasaki H, Shibata S, Ohashi M, Hakamada K, Sasaki M, Kijima H. :
Decreased expression of claudin-1 is correlated with recurrence status in esophageal squamous cell
carcinoma. Biomed Res. 2008;29(2):71-6.
23. Mizukami Y, Kono K, Maruyama T, Watanabe M, Kawaguchi Y, Kamimura K, Fujii H.: Downregulation
of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with
oesophageal squamous cell carcinoma. Br J Cancer. 2008;99(9):1462-7.
24. Mroczko B, Koz³owski M, Groblewska M, £ukaszewicz M, Nikliòski J, Jelski W, Laudaòski J, Chyczewski L,
Szmitkowski M.: The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9),
squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal
cancer patients. Clin Chim Acta. 2008;389(1-2):61-6.
25. Nam TK, Lee JH, Cho SH, Chung IJ, Ahn SJ, Song JY, Yoon MS, Chung WK, Nah BS.: Low hMLH1
expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell
carcinoma. Cancer Lett. 2008 Feb 18;260(1-2):109-17.
26. Ohta M, Mimori K, Fukuyoshi Y, Kita Y, Motoyama K, Yamashita K, Ishii H, Inoue H, Mori M.: Clinical
significance of the reduced expression of G protein gamma 7 (GNG7) in oesophageal cancer. Br J Cancer.
2008;98(2):410-7.
27. Okumura M, Kajiyama Y, Takeda K, Okumura K, Tsurumaru M.: Correlation between loss of Bcl-XL
expression and improved prognosis in advanced esophageal cancer treated by preoperative chemoradiotherapy.
Eur Surg Res. 2008;41(3):260-6.
28. Rades D, Golke H, Schild SE, Kilic E.: Impact of VEGF and VEGF receptor 1 (FLT1) expression on
the prognosis of stage III esophageal cancer patients after radiochemotherapy. Strahlenther Onkol.
2008;184(8):416-20.
29. Rades D, Golke H, Schild SE, Kilic E.: The impact of tumor expression of erythropoietin receptors and
erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation. Int J
Radiat Oncol Biol Phys. 2008;71(1):152-9.
30. Ressiot E, Dahan L, Liprandi A, Giorgi R, Djourno XB, Padovani L, Alibert S, Ries P, Laquiere A,
Laugier R, Thomas P, Seitz JF.: Predictive factors of the response to chemoradiotherapy in esophageal
cancer. Gastroenterol Clin Biol. 2008;32(6-7):567-77.
31. Sano A, Kato H, Sakurai S, Sakai M, Tanaka N, Inose T, Saito K, Sohda M, Nakajima M, Nakajima T,
Kuwano H. CD24: Expression Is a Novel Prognostic Factor in Esophageal Squamous Cell Carcinoma.
Gastro 2009.qxd 5/9/2009 1:41 PM Page 88
A nyelõcsõ 89
Ann Surg Oncol. 2008 Dec 3. [Epub ahead of print]
32. Shimada H, Shiratori T, Takeda A, Matsushita K, Okazumi S, Akutsu Y, Matsubara H, Nomura F, Ochiai T.:
Perioperative Changes of Serum p53 Antibody Titer is a Predictor for Survival in Patients with
Esophageal Squamous Cell Carcinoma. World J Surg. 2008 Dec 4. [Epub ahead of print]
33. Tanaka N, Kato H, Inose T, Kimura H, Faried A, Sohda M, Nakajima M, Fukai Y, Miyazaki T, Masuda N,
Fukuchi M, Kuwano H.: Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is
associated with poor prognosis in oesophageal squamous cell carcinoma. Br J Cancer. 2008;99(9):1468-75.
34. Tateno T, Ueno S, Hiwatashi K, Matsumoto M, Okumura H, Setoyama T, Uchikado Y, Sakoda M, Kubo F,
Ishigami S, Shinchi H, Natsugoe S.: Expression of Receptor for Advanced Glycation End Products
(RAGE) is Related to Prognosis in Patients with Esophageal Squamous Cell Carcinoma. Ann Surg
Oncol. 2008 Nov 20. [Epub ahead of print]
35. Tonomoto Y, Tachibana M, Dhar DK, Onoda T, Hata K, Ohnuma H, Tanaka T, Nagasue N.: Differential
expression of RUNX genes in human esophageal squamous cell carcinoma: downregulation of RUNX3
worsens patient prognosis. Oncology. 2007;73(5-6):346-56.
36. Wang J, Sasco AJ, Fu C, Xue H, Guo G, Hua Z, Zhou Q, Jiang Q, Xu B.: Aberrant DNA methylation
of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in
esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2008;17(1):118-25.
37. Xu S, Kitayama J, Yamashita H, Souma D, Nagawa H.: Nuclear translocation of HER-4/c-erbB-4 is
significantly correlated with prognosis of esophageal squamous cell carcinoma. J Surg Oncol.
2008;97(1):44-50.
38. Yoshioka A, Miyata H, Doki Y, Yasuda T, Yamasaki M, Motoori M, Okada K, Matsuyama J, Makari Y,
Sohma I, Takiguchi S, Fujiwara Y, Monden M.: The activation of Akt during preoperative chemotherapy
for esophageal cancer correlates with poor prognosis. Oncol Rep. 2008;19(5):1099-107.
39. Yoshioka T, Miyamoto M, Cho Y, Ishikawa K, Tsuchikawa T, Kadoya M, Li L, Mishra R, Ichinokawa K,
Shoji Y, Matsumura Y, Shichinohe T, Hirano S, Shinohara T, Itoh T, Kondo S.: Infiltrating regulatory T cell
numbers is not a factor to predict patient’s survival in oesophageal squamous cell carcinoma. Br J Cancer.
2008;98(7):1258-63.
40. Yuen HF, Chan YP, Law S, Srivastava G, El-Tanani M, Mak TW, Chan KW. DJ-1: Could Predict Worse
Prognosis in Esophageal Squamous Cell Carcinoma. Cancer Epidemiol Biomarkers Prev.
2008;17(12):3593-602.
